Safety and efficacy of immunotherapy according to the age threshold of 80 years.
Mebarki S, Pamoukdjian F, Pierro M, Poisson J, Baldini C, Widad Lahlou, Taieb J, Fabre E, Canoui-Poitrine F, Oudard S, Paillaud E.
Mebarki S, et al. Among authors: pamoukdjian f.
Bull Cancer. 2023 May;110(5):570-580. doi: 10.1016/j.bulcan.2023.02.010. Epub 2023 Mar 7.
Bull Cancer. 2023.
PMID: 36894391
Free article.
Review.